Rajat Gupta earned his MS in Biotechnology from the University of Central Florida in the laboratory of Dr Sampath Parthasarathy, where he studied the effects of the breakdown products of fatty acid peroxides on the induction of apolipoprotein A1. The desire to learn more about complex gene-environment interactions in cardiometabolic diseases brought him to University of California Los Angeles, where he is currently pursuing his PhD in the Molecular Toxicology interdepartmental program (mentor, Dr Jesus Araujo). His interest lies in studying the role of oxidative stress in vascular diseases and the mechanisms of how air pollutants (such as ultrafine particles and diesel exhaust emissions) promote atherosclerosis. His research also focuses on studying the cardiovascular health effects of electronic cigarette use in young adults. In the future, he aspires to work as an independent scientist in a leading Biotechnology industry. Outside of work, he enjoys yoga-meditation, swimming, tennis and spending quality time with friends and family. He is always keen on participating in water sports and exploring beach towns.

Dr Maria Bartosova earned a MS in Biotechnology from Comenius University, Bratislava, Slovakia and her PhD from Heidelberg University, Germany, within the Marie Curie-funded network European Training and Research in Peritoneal Dialysis (EuTRiPD). Currently she is working as DFG-funded postdoctoral fellow at Heidelberg University Hospital in Dr Claus Schmitt’s lab. She is organizing the International Peritoneal Biobank and focused on peritoneal and cardiovascular health of (pediatric) patients with chronic kidney disease, on peritoneal dialysis and after transplantation. Her most recent work reveals the glucose derivative induced molecular pathomechanisms of vascular disease in children on peritoneal dialysis.

Dr Martin Schlegel is an anesthesiologist and scientist at the Technical University Munich. During his doctoral training with Prof. Mirakaj at the University of Tuebingen, Dr Schlegel became interested in the role of neuronal guidance proteins in acute inflammation. With a DFG funded scholarship he pursued his postdoctoral training with Dr Kathryn Moore at NYU, focusing on the mechanisms of chronic inflammation and how murine neuronal guidance proteins alter the resolution of inflammation and plaque regression in atherosclerosis. After his return to Germany Dr Schlegel started his own lab at the Technical University Munich. His lab focuses on the translation of basic research on inflammation to clinic trials on ICU.

When he is not in the clinic or lab, Dr Schlegel enjoys spending time with his wife and kids and loves to travel and discover gins. Dr Schlegel can be found on Twitter @PMSchlegel.

Dr Jiabing Rong earned his BS and PhD from Zhejiang University and now is a clinician in the Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine. He will continue postdoctoral training in the laboratory of Dr Jian’an Wang over the next three years. He focuses on investigating novel functions and mechanisms of renin-angiotensin system in cardiovascular diseases. In the future, he aims to be more involved in translational research on cardiovascular diseases.

Dr Ryan Hoiland is a postdoctoral fellow at the University of British Columbia and Vancouver General Hospital, in Vancouver, Canada. He completed his Bachelor of Human Kinetics followed by his Master of Science and PhD in Health and Exercise Sciences at the University of British Columbia Okanagan. Ryan began his graduate studies with a keen interest in high-altitude adaptation and physiologic responses to hypoxia in humans. Since the completion of his PhD, his postdoctoral research has focused on the pathophysiology of central nervous system hypoxia in the setting of cardiac arrest and spinal cord injury.

Dr Mypinder Sekhon completed his medical school, internal medicine residency and critical care medicine fellowship at the University of British Columbia. Subsequently, he completed a neurocritical care fellowship at the University of Cambridge and is a Clinical Assistant Professor at the University of British Columbia and a staff intensivist at Vancouver General Hospital. He completed his PhD in cerebrovascular sciences and his research program focuses on delineating the pathophysiology of hypoxic ischemic brain injury following cardiac arrest using a combined translational approach of multimodal neuromonitoring and cellular/molecular based analytics.

拉贾特·古普塔在中佛罗里达大学 Sampath Parthasarathy 博士的实验室获得生物技术硕士学位，在那里他研究了脂肪酸过氧化物的分解产物对载脂蛋白 A1 诱导的影响。为了更多地了解心脏代谢疾病中复杂的基因 - 环境相互作用，他来到加州大学洛杉矶分校，目前正在那里攻读分子毒理学跨部门项目的博士学位（导师 Jesus Araujo 博士）。他的兴趣在于研究氧化应激在血管疾病中的作用以及空气污染物（如超细颗粒和柴油机尾气排放）如何促进动脉粥样硬化的机制。他的研究还侧重于研究年轻人使用电子烟对心血管健康的影响。将来，他渴望在领先的生物技术行业担任独立科学家。工作之余，他喜欢瑜伽冥想、游泳、网球以及与朋友和家人共度美好时光。他一直热衷于参与水上运动和探索海滨小镇。

Maria Bartosova 博士获得了斯洛伐克布拉迪斯拉发 Comenius 大学的生物技术硕士学位和德国海德堡大学的博士学位，该网络属于玛丽居里资助的欧洲腹膜透析培训和研究网络 (EuTRiPD)。目前，她在克劳斯·施密特博士实验室的海德堡大学医院担任 DFG 资助的博士后研究员。她正在组织国际腹膜生物库，专注于慢性肾病（儿科）患者的腹膜和心血管健康、腹膜透析和移植后。她最近的工作揭示了葡萄糖衍生物诱导腹膜透析儿童血管疾病的分子病理机制。

Martin Schlegel 博士是慕尼黑工业大学的麻醉师和科学家。在图宾根大学与 Mirakaj 教授一起接受博士培训期间，Schlegel 博士对神经元引导蛋白在急性炎症中的作用产生了兴趣。凭借 DFG 资助的奖学金，他在纽约大学与 Kathryn Moore 博士一起进行博士后培训，重点研究慢性炎症的机制以及鼠神经元指导蛋白如何改变动脉粥样硬化中炎症的消退和斑块消退。回到德国后，施莱格尔博士在慕尼黑工业大学开设了自己的实验室。他的实验室专注于将炎症的基础研究转化为 ICU 的临床试验。

当他不在诊所或实验室时，Schlegel 博士喜欢与妻子和孩子共度时光，喜欢旅行和发现杜松子酒。可以在 Twitter @PMSchlegel 上找到 Schlegel 博士。

荣家兵医生在浙江大学获得学士和博士学位，现为浙江大学医学院附属第二医院心内科临床医师。未来三年，他将继续在王建安博士的实验室进行博士后培训。他专注于研究肾素-血管紧张素系统在心血管疾病中的新功能和机制。未来，他的目标是更多地参与心血管疾病的转化研究。

Ryan Hoiland 博士是不列颠哥伦比亚大学和加拿大温哥华温哥华总医院的博士后研究员。他在不列颠哥伦比亚大学奥肯那根大学获得人体动力学学士学位，随后获得了健康与运动科学硕士学位和博士学位。瑞安 (Ryan) 开始他的研究生学习时，对高海拔适应和人类对缺氧的生理反应产生了浓厚的兴趣。自完成博士学位以来，他的博士后研究重点是心脏骤停和脊髓损伤情况下中枢神经系统缺氧的病理生理学。

Mypinder Sekhon 博士在不列颠哥伦比亚大学完成了他的医学院、内科住院医师和重症监护医学研究。随后，他在剑桥大学完成了神经重症监护奖学金，是不列颠哥伦比亚大学的临床助理教授和温哥华总医院的重症监护医师。他完成了脑血管科学博士学位，他的研究项目侧重于使用多模式神经监测和细胞/分子分析的组合转化方法描绘心脏骤停后缺氧缺血性脑损伤的病理生理学。